August 12, 2020 -Save MolecuLight i:X fluorescence wound images and measurements in Epic
Toronto, CANADA – (August 12, 2020) MolecuLight Inc., the leader in point-of-care fluorescence imaging for real-time detection of bacteria in wounds, announces the availability of its MolecuLight i:X® platform on the Epic App Orchard Marketplace and the integration
… Read MoreJuly 31, 2020 -10 Posters and Videos on Benefits of MolecuLight Device for Wound Care
Toronto, CANADA – (July 31, 2020) MolecuLight Inc., the leader in point-of-care fluorescence imaging for real-time detection of bacteria in wounds, announces the presentation of 10 Clinical Posters and Video Presentations at the Symposium of Wound
… Read MoreJuly 16, 2020 -New Telemedicine Solution allows the MolecuLight i:X Device to be used at the Bedside
Toronto, CANADA – (July 16, 2020) MolecuLight Inc., the leader in point-of-care fluorescence imaging for real-time detection of bacteria in wounds, announces the launch of its new i:X®Telemedicine Solution. The i:X Telemedicine Solution provides
… Read MoreJuly 9, 2020 -New Disposable Sleeve allows MolecuLight i:X to Be Used in Operating Rooms and Covid-19 Wards
Toronto, CANADA – (July 9, 2020) MolecuLight Inc., the leader in point-of-care fluorescence imaging for real-time detection of bacteria in wounds, announces the launch of its new i:X Sterile Surgical Sleeve Convenience Kit for
… Read MoreJune 15, 2020 -Leading GPO Accepts MolecuLight i:X Wound Care Device for National Membership
Toronto, CANADA – (June 15, 2020) MolecuLight Inc., the leader in point-of-care fluorescence imaging for real-time detection of bacteria in wounds, announces the availability of its MolecuLight i:X® platform to 9,000 healthcare facilities in the US through its
… Read MoreJune 11, 2020 -New Code Enables Reimbursement to Hospital Outpatient Centers Using MolecuLight i:X
Toronto, CANADA – (June 11, 2020) MolecuLight Inc., the leader in point-of-care fluorescence imaging for real-time detection of bacteria in wounds, announces that the Centers for Medicare & Medicaid Services (CMS) has assigned an Ambulatory Payment Classification
… Read MoreApril 1, 2020 -Novel Virtual Conference Attracts 10,000 Wound Care Professionals
Toronto, CANADA and Atlantic Beach, USA – (April 1, 2020) MolecuLight Inc., the leader in point-of-care fluorescence imaging for real-time detection of bacteria in wounds, announces its Sponsorship and participation in the Virtual Exhibit of its MolecuLight i:X®Platform at WoundCon™ Spring 2020.
… Read MoreMarch 3, 2020 -Study Demonstrates Red Fluorescence from 88% of Planktonic and Biofilm Wound Pathogens Using i:X
Toronto, CANADA – (March 3, 2020) MolecuLight Inc., the world’s leader in handheld fluorescence imaging for real-time detection of bacteria in wounds, announces the publication of “In vitro detection of porphyrin-producing wound bacteria with real-time
… Read MoreFebruary 20, 2020 -MolecuLight i:X Provides Accurate Detection and Wound Documentation
Toronto, CANADA – (February 20, 2020) MolecuLight Inc., the world’s leader in handheld fluorescence imaging for real-time detection of bacteria in wounds, released a significant upgrade to its i:X digital wound measurement feature that enables clinicians to more accurately and quickly capture
… Read More
MolecuLight is SOC ll®
Type l Accredited:
MolecuLight awarded
Premier’s
Technology
Breakthrough Designation
MolecuLight
i:X
is designated as a:
MolecuLight included
in ISWCAP Consensus
Guidelines:
MolecuLight is a proud
corporate member of:
©2026
The MolecuLight® i:X and MolecuLightDX™ Imaging Devices are approved by Health Canada for sale in Canada and has CE marking for sale in the European Union.
The MolecuLight™ i:X and DX Imaging Devices have received FDA clearance.